
### [MONDO:0001166](http://purl.obolibrary.org/obo/MONDO_0001166)
**Label:** nephritis

**Subclasses:** [MONDO:0013892](http://purl.obolibrary.org/obo/MONDO_0013892) (C3 glomerulonephritis), [MONDO:0013496](http://purl.obolibrary.org/obo/MONDO_0013496) (IGAN2), [MONDO:0017236](http://purl.obolibrary.org/obo/MONDO_0017236) (rapidly progressive glomerulonephritis), [MONDO:0019736](http://purl.obolibrary.org/obo/MONDO_0019736) (dense deposit disease), [MONDO:0014786](http://purl.obolibrary.org/obo/MONDO_0014786) (Iga nephropathy, susceptibility to, 3; IGAN3), [MONDO:0014005](http://purl.obolibrary.org/obo/MONDO_0014005) (immunoglobulin-mediated membranoproliferative glomerulonephritis), [MONDO:0001645](http://purl.obolibrary.org/obo/MONDO_0001645) (crescentic glomerulonephritis (disease)), [MONDO:0016061](http://purl.obolibrary.org/obo/MONDO_0016061) (immunodeficiency with factor H anomaly), [MONDO:0006835](http://purl.obolibrary.org/obo/MONDO_0006835) (lipoid nephrosis), [MONDO:0001644](http://purl.obolibrary.org/obo/MONDO_0001644) (acute proliferative glomerulonephritis), [MONDO:0001184](http://purl.obolibrary.org/obo/MONDO_0001184) (chronic rapidly progressive glomerulonephritis), [MONDO:0001085](http://purl.obolibrary.org/obo/MONDO_0001085) (interstitial nephritis), [MONDO:0005342](http://purl.obolibrary.org/obo/MONDO_0005342) (IgA glomerulonephritis), [MONDO:0012105](http://purl.obolibrary.org/obo/MONDO_0012105) (Wegener's granulomatosis), [MONDO:0003140](http://purl.obolibrary.org/obo/MONDO_0003140) (immune-complex glomerulonephritis), [MONDO:0018904](http://purl.obolibrary.org/obo/MONDO_0018904) (primary membranoproliferative glomerulonephritis), [MONDO:0013898](http://purl.obolibrary.org/obo/MONDO_0013898) (karyomegalic interstitial nephritis), [MONDO:0019738](http://purl.obolibrary.org/obo/MONDO_0019738) (atypical hemolytic-uremic syndrome with H factor anomaly), [MONDO:0008072](http://purl.obolibrary.org/obo/MONDO_0008072) (IGAN1), [MONDO:0019988](http://purl.obolibrary.org/obo/MONDO_0019988) (Pauci-immune glomerulonephritis with ANCA), [MONDO:0012350](http://purl.obolibrary.org/obo/MONDO_0012350) (complement factor H deficiency), [MONDO:0019989](http://purl.obolibrary.org/obo/MONDO_0019989) (Pauci-immune glomerulonephritis without ANCA), [MONDO:0018159](http://purl.obolibrary.org/obo/MONDO_0018159) (atypical hemolytic-uremic syndrome with DGKE deficiency), [MONDO:0019641](http://purl.obolibrary.org/obo/MONDO_0019641) (pauci-immune glomerulonephritis), [MONDO:0018013](http://purl.obolibrary.org/obo/MONDO_0018013) (non-immunoglobulin-mediated membranoproliferative glomerulonephritis), [MONDO:0003139](http://purl.obolibrary.org/obo/MONDO_0003139) (mesangial proliferative glomerulonephritis), [MONDO:0003138](http://purl.obolibrary.org/obo/MONDO_0003138) (subacute glomerulonephritis), [MONDO:0007416](http://purl.obolibrary.org/obo/MONDO_0007416) (Balkan nephropathy), [MONDO:0003135](http://purl.obolibrary.org/obo/MONDO_0003135) (focal embolic glomerulonephritis), [MONDO:0005556](http://purl.obolibrary.org/obo/MONDO_0005556) (lupus nephritis), [MONDO:0001870](http://purl.obolibrary.org/obo/MONDO_0001870) (acute poststreptococcal glomerulonephritis), [MONDO:0003134](http://purl.obolibrary.org/obo/MONDO_0003134) (proliferative glomerulonephritis), [MONDO:0005334](http://purl.obolibrary.org/obo/MONDO_0005334) (nephritis, hereditary), [MONDO:0003137](http://purl.obolibrary.org/obo/MONDO_0003137) (diffuse glomerulonephritis), [MONDO:0001871](http://purl.obolibrary.org/obo/MONDO_0001871) (acute diffuse glomerulonephritis), [MONDO:0003136](http://purl.obolibrary.org/obo/MONDO_0003136) (anti-basement membrane glomerulonephritis), [MONDO:0005376](http://purl.obolibrary.org/obo/MONDO_0005376) (membranous glomerulonephritis), [MONDO:0002462](http://purl.obolibrary.org/obo/MONDO_0002462) (glomerulonephritis (disease)), [MONDO:0003133](http://purl.obolibrary.org/obo/MONDO_0003133) (exudative glomerulonephritis), [MONDO:0002461](http://purl.obolibrary.org/obo/MONDO_0002461) (membranoproliferative glomerulonephritis (disease)), [MONDO:0010596](http://purl.obolibrary.org/obo/MONDO_0010596) (membranoproliferative glomerulonephritis, X-linked), 

**Mapped go classes:** [GO:0040037](http://purl.obolibrary.org/obo/GO_0040037) (negative regulation of fibroblast growth factor receptor signaling pathway), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0015630](http://purl.obolibrary.org/obo/GO_0015630) (microtubule cytoskeleton), [GO:0036297](http://purl.obolibrary.org/obo/GO_0036297) (interstrand cross-link repair), [GO:0060449](http://purl.obolibrary.org/obo/GO_0060449) (bud elongation involved in lung branching), [GO:0006289](http://purl.obolibrary.org/obo/GO_0006289) (nucleotide-excision repair), [GO:0048754](http://purl.obolibrary.org/obo/GO_0048754) (branching morphogenesis of an epithelial tube), [GO:0004143](http://purl.obolibrary.org/obo/GO_0004143) (diacylglycerol kinase activity), [GO:0060841](http://purl.obolibrary.org/obo/GO_0060841) (venous blood vessel development), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0045171](http://purl.obolibrary.org/obo/GO_0045171) (intercellular bridge), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0140036](http://purl.obolibrary.org/obo/GO_0140036) (ubiquitin-dependent protein binding), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0034260](http://purl.obolibrary.org/obo/GO_0034260) (negative regulation of GTPase activity), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0009966](http://purl.obolibrary.org/obo/GO_0009966) (regulation of signal transduction), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0031345](http://purl.obolibrary.org/obo/GO_0031345) (negative regulation of cell projection organization), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0016788](http://purl.obolibrary.org/obo/GO_0016788) (hydrolase activity, acting on ester bonds), [GO:0060541](http://purl.obolibrary.org/obo/GO_0060541) (respiratory system development), [GO:0043407](http://purl.obolibrary.org/obo/GO_0043407) (negative regulation of MAP kinase activity), [GO:0033683](http://purl.obolibrary.org/obo/GO_0033683) (nucleotide-excision repair, DNA incision), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0060425](http://purl.obolibrary.org/obo/GO_0060425) (lung morphogenesis), [GO:0046834](http://purl.obolibrary.org/obo/GO_0046834) (lipid phosphorylation), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0051387](http://purl.obolibrary.org/obo/GO_0051387) (negative regulation of neurotrophin TRK receptor signaling pathway), [GO:0045595](http://purl.obolibrary.org/obo/GO_0045595) (regulation of cell differentiation), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0017108](http://purl.obolibrary.org/obo/GO_0017108) (5'-flap endonuclease activity), [GO:0043539](http://purl.obolibrary.org/obo/GO_0043539) (protein serine/threonine kinase activator activity), [GO:0000724](http://purl.obolibrary.org/obo/GO_0000724) (double-strand break repair via homologous recombination), [GO:0007205](http://purl.obolibrary.org/obo/GO_0007205) (protein kinase C-activating G-protein coupled receptor signaling pathway), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0003951](http://purl.obolibrary.org/obo/GO_0003951) (NAD+ kinase activity), [GO:0008409](http://purl.obolibrary.org/obo/GO_0008409) (5'-3' exonuclease activity), [GO:0000132](http://purl.obolibrary.org/obo/GO_0000132) (establishment of mitotic spindle orientation), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0004528](http://purl.obolibrary.org/obo/GO_0004528) (phosphodiesterase I activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010801](http://purl.obolibrary.org/obo/GO_0010801) (negative regulation of peptidyl-threonine phosphorylation), [GO:0004527](http://purl.obolibrary.org/obo/GO_0004527) (exonuclease activity), [GO:0070373](http://purl.obolibrary.org/obo/GO_0070373) (negative regulation of ERK1 and ERK2 cascade), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0070336](http://purl.obolibrary.org/obo/GO_0070336) (flap-structured DNA binding), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0017108](http://purl.obolibrary.org/obo/GO_0017108) (5'-flap endonuclease activity) 52.78%
- [GO:0016893](http://purl.obolibrary.org/obo/GO_0016893) (endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters) and [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) 52.78%
- [GO:0016888](http://purl.obolibrary.org/obo/GO_0016888) (endodeoxyribonuclease activity, producing 5'-phosphomonoesters) and [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) 52.78%
- Thing 52.71%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) 38.13%
- [GO:0016888](http://purl.obolibrary.org/obo/GO_0016888) (endodeoxyribonuclease activity, producing 5'-phosphomonoesters) 38.13%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 38.13%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 38.13%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 38.13%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 38.13%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 38.13%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 38.13%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 38.13%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 38.13%
- [GO:0048256](http://purl.obolibrary.org/obo/GO_0048256) (flap endonuclease activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 38.13%


